These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 12112043

  • 1. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.
    Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM.
    Ann Neurol; 2002 Jul; 52(1):20-8. PubMed ID: 12112043
    [Abstract] [Full Text] [Related]

  • 2. Randomized, controlled trial of insulin for acute poststroke hyperglycemia.
    McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW.
    Ann Neurol; 2010 May; 67(5):570-8. PubMed ID: 20437554
    [Abstract] [Full Text] [Related]

  • 3. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
    Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, Munuera J, Alvarez-Sabin J.
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452
    [Abstract] [Full Text] [Related]

  • 4. Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke.
    Buck BH, Liebeskind DS, Saver JL, Bang OY, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Yun SW, Razinia T, Ovbiagele B.
    Arch Neurol; 2007 Sep; 64(9):1287-91. PubMed ID: 17846267
    [Abstract] [Full Text] [Related]

  • 5. Measurement of brain temperature with magnetic resonance spectroscopy in acute ischemic stroke.
    Karaszewski B, Wardlaw JM, Marshall I, Cvoro V, Wartolowska K, Haga K, Armitage PA, Bastin ME, Dennis MS.
    Ann Neurol; 2006 Oct; 60(4):438-46. PubMed ID: 16972284
    [Abstract] [Full Text] [Related]

  • 6. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [Abstract] [Full Text] [Related]

  • 7. Automatic prediction of infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps.
    Montiel NH, Rosso C, Chupin N, Deltour S, Bardinet E, Dormont D, Samson Y, Baillet S.
    Acad Radiol; 2008 Jan; 15(1):77-83. PubMed ID: 18078910
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
    Kumar S, Savitz S, Schlaug G, Caplan L, Selim M.
    Neurology; 2006 Apr 25; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
    [Abstract] [Full Text] [Related]

  • 9. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P.
    J Neurol Sci; 2004 Oct 15; 225(1-2):3-9. PubMed ID: 15465079
    [Abstract] [Full Text] [Related]

  • 10. Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke.
    Lu M, Mitsias PD, Ewing JR, Soltanian-Zadeh H, Bagher-Ebadian H, Zhao Q, Oja-Tebbe N, Patel SC, Chopp M.
    J Magn Reson Imaging; 2005 May 15; 21(5):495-502. PubMed ID: 15834917
    [Abstract] [Full Text] [Related]

  • 11. Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke.
    Allport LE, Parsons MW, Butcher KS, MacGregor L, Desmond PM, Tress BM, Davis SM.
    Neurology; 2005 Nov 08; 65(9):1382-7. PubMed ID: 16275824
    [Abstract] [Full Text] [Related]

  • 12. Etiology of perfusion-diffusion magnetic resonance imaging mismatch patterns.
    Restrepo L, Jacobs MA, Barker PB, Beauchamp NJ, Skolasky RL, Keswani SC, Wityk RJ.
    J Neuroimaging; 2005 Jul 08; 15(3):254-60. PubMed ID: 15951408
    [Abstract] [Full Text] [Related]

  • 13. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].
    Feng XY, Liang J, Yin XD, Han X, Dong Q, Lü CZ.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):952-7. PubMed ID: 12899795
    [Abstract] [Full Text] [Related]

  • 14. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial.
    De Silva DA, Ebinger M, Christensen S, Parsons MW, Levi C, Butcher K, Barber PA, Bladin C, Donnan GA, Davis SM, Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators.
    Cerebrovasc Dis; 2010 Jun 10; 29(1):14-21. PubMed ID: 19893307
    [Abstract] [Full Text] [Related]

  • 15. Acute ischemic stroke lesion measurement on diffusion-weighted imaging--important considerations in designing acute stroke trials with magnetic resonance imaging.
    Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Hand PJ, Dennis MS.
    J Stroke Cerebrovasc Dis; 2007 Jun 10; 16(2):64-70. PubMed ID: 17689396
    [Abstract] [Full Text] [Related]

  • 16. MR diffusion-weighted imaging and outcome prediction after ischemic stroke.
    Hand PJ, Wardlaw JM, Rivers CS, Armitage PA, Bastin ME, Lindley RI, Dennis MS.
    Neurology; 2006 Apr 25; 66(8):1159-63. PubMed ID: 16525124
    [Abstract] [Full Text] [Related]

  • 17. Persistent hyperglycemia at 24-48 h in acute hyperglycemic stroke patients is not associated with a worse functional outcome.
    Ntaios G, Abatzi C, Alexandrou M, Lambrou D, Chatzopoulos S, Egli M, Ruiz J, Bornstein N, Michel P.
    Cerebrovasc Dis; 2011 Apr 25; 32(6):561-6. PubMed ID: 22104640
    [Abstract] [Full Text] [Related]

  • 18. 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke.
    Kosior RK, Wright CJ, Kosior JC, Kenney C, Scott JN, Frayne R, Hill MD.
    Cerebrovasc Dis; 2007 Apr 25; 24(4):361-8. PubMed ID: 17690549
    [Abstract] [Full Text] [Related]

  • 19. Natural history of blood glucose within the first 48 hours after ischemic stroke.
    Wong AA, Schluter PJ, Henderson RD, O'Sullivan JD, Read SJ.
    Neurology; 2008 Mar 25; 70(13):1036-41. PubMed ID: 18362283
    [Abstract] [Full Text] [Related]

  • 20. The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials.
    Barber PA, Parsons MW, Desmond PM, Bennett DA, Donnan GA, Tress BM, Davis SM.
    J Neuroimaging; 2004 Apr 25; 14(2):123-32. PubMed ID: 15095557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.